Andressa Forni Obice, PA
Physician Assistant · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 2
- 1 carrier
- Offices
- 2
Offices
2 locations · University Healthcare Alliance · 334 clinicians in this group
Looking this up.
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
2 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Andressa Forni Obice’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$23,109
Medicare paid this office $23,109 for 187 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 106 | $8,478 | $62 |
| Return visit (30+ min) | 52 | $5,412 | $89 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 21 | $2,994 | $143 |
| New patient visit (30+ min) | 14 | $608 | $43 |
| Administration of influenza virus vaccine | 11 | $420 | $38 |
See all 6 services
| Short return visit (20+ min) | 106 | $8,478 | $62 |
| Return visit (30+ min) | 52 | $5,412 | $89 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 21 | $2,994 | $143 |
| New patient visit (30+ min) | 14 | $608 | $43 |
| Administration of influenza virus vaccine | 11 | $420 | $38 |
| Automated urinalysis test | 12 | $31 | $2 |
Who their Medicare patients are
187 Original Medicare patients in 2024. Average age 74 · Women 65% · Also on Medicaid 6% · Health risk score 1.05. At or below the middle of the specialty; the typical physician assistant clinician is at 1.31.
Conditions among them: High blood pressure 66% · Diabetes 20% · Coronary heart disease 20% · Cancer 19% · Atrial fibrillation 15% · Chronic kidney disease 14% · Depression 13% · Heart failure 12% · Stroke 9% · Dementia 7% · COPD 6%.
The office billed $105,212, Medicare allowed $33,353 and paid $23,109; for 541 services of 28 kinds; $1,312 of it was for drugs given in the office and $21,797 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 187 | 541 | 74 | 1.05 | $105,212 | $23,109 |
| 2023 | 221 | 1,090 | 74 | 1.06 | $185,588 | $42,485 |
| 2022 | 258 | 1,877 | 75 | 1.07 | $244,433 | $64,347 |
| 2021 | 43 | 273 | 75 | 1.17 | $34,515 | $9,326 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 14 services
| Return visit (30+ min) | 93 | $9,943 | $76 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 54 | $6,344 | $117 |
| Short return visit (20+ min) | 93 | $5,681 | $53 |
| New patient visit (45+ min) | 17 | $1,400 | $82 |
| New patient visit (30+ min) | 23 | $1,400 | $61 |
| Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | 15 | $608 | $41 |
| Telephone medical discussion with physician, 11-20 minutes | 11 | $598 | $54 |
| Adm sarscv2 bvl 50mcg/.5ml a | 11 | $415 | $38 |
| Administration of influenza virus vaccine | 11 | $318 | $29 |
| Hemoglobin a1c level | 18 | $267 | $10 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 14 | $227 | $16 |
| Injection of drug or substance under skin or into muscle | 12 | $138 | $11 |
| Urinalysis, manual test | 16 | $55 | $3 |
| Sarscov2 vac bvl 50mcg/0.5ml | 11 | $0 | $0 |
2022: 17 services
| Injection, denosumab, 1 mg | 17 | $19,388 | None |
| Return visit (30+ min) | 129 | $15,979 | $84 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 54 | $6,649 | $123 |
| New patient visit (45+ min) | 47 | $4,638 | $99 |
| Short return visit (20+ min) | 55 | $3,842 | $60 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 26 | $1,811 | $70 |
| New patient visit (30+ min) | 22 | $1,548 | $70 |
| Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 50 mcg/0.25ml dosage, booster dose | 26 | $991 | $38 |
| Administration of influenza virus vaccine | 29 | $829 | $29 |
| Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | 18 | $817 | $41 |
| Hemoglobin a1c level | 38 | $413 | $9 |
| Administration of pneumococcal vaccine | 12 | $345 | $29 |
| Injection of drug or substance under skin or into muscle | 19 | $231 | $10 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 24 | $217 | $8 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 11 | $196 | $16 |
| Urinalysis, manual test | 13 | $48 | $3 |
| Severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 50 mcg/0.25ml dosage, for intramuscular use | 26 | $0 | $0 |
2021: 2 services
| Return visit (30+ min) | 16 | $1,748 | $87 |
| Short return visit (20+ min) | 13 | $1,029 | $69 |
Drugs they prescribed that Part D paid
$18,614
Pharmacies billed $18,614 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
379 generic and fewer than 11 brand-name prescriptions · $18,614 in drug cost · 47 antibiotic prescriptions to 43 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Rosuvastatin | 16 | $246 | $15 |
| Lisinopril | 19 | $171 | $9 |
| Losartan | 16 | $161 | $10 |
| Albuterol Sulfate Hfa | 14 | $153 | $11 |
| Pravastatin | 12 | $148 | $12 |
See all 10 drugs
| Rosuvastatin | 16 | $246 | $15 |
| Lisinopril | 19 | $171 | $9 |
| Losartan | 16 | $161 | $10 |
| Albuterol Sulfate Hfa | 14 | $153 | $11 |
| Pravastatin | 12 | $148 | $12 |
| Levothyroxine | 17 | $144 | $8 |
| Amlodipine Besylate | 25 | $142 | $6 |
| Atorvastatin | 22 | $141 | $6 |
| Azithromycin | 15 | $59 | $4 |
| Metformin | 16 | $51 | $3 |
Year by year
| 2024 | 411 | 208 | None | None | $18,614 |
| 2023 | 650 | 166 | None | 11% | $80,201 |
| 2022 | 561 | 146 | None | None | $50,740 |
| 2021 | 18 | 11 | 0% (0) | None | $1,092 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 15 drugs
| Jardiance | 16 | $30,260 | $1,891 |
| Levothyroxine | 42 | $846 | $20 |
| Rosuvastatin | 22 | $769 | $35 |
| Duloxetine | 14 | $764 | $55 |
| Atorvastatin | 68 | $727 | $11 |
| Metoprolol | 21 | $488 | $23 |
| Omeprazole | 30 | $413 | $14 |
| Pravastatin | 13 | $398 | $31 |
| Amlodipine Besylate | 31 | $379 | $12 |
| Metformin | 21 | $324 | $15 |
| Lisinopril | 18 | $245 | $14 |
| Gabapentin | 14 | $172 | $12 |
| Lagevrio (Eua) | 12 | $125 | $10 |
| Azithromycin | 11 | $68 | $6 |
| Amoxicillin-Clavulanate Potass | 11 | $55 | $5 |
2022: 12 drugs
| Jardiance | 12 | $13,271 | $1,106 |
| Toujeo Solostar | 11 | $7,610 | $692 |
| Valsartan | 29 | $557 | $19 |
| Levothyroxine | 37 | $548 | $15 |
| Albuterol Sulfate Hfa | 11 | $505 | $46 |
| Atorvastatin | 56 | $394 | $7 |
| Gabapentin | 15 | $180 | $12 |
| Rosuvastatin | 13 | $142 | $11 |
| Metformin | 26 | $128 | $5 |
| Lisinopril | 13 | $123 | $9 |
| Omeprazole | 11 | $111 | $10 |
| Amlodipine Besylate | 22 | $93 | $4 |
Money from drug and device companies
$163 in 2021
A payment is not proof that care is biased.
See all 2 published payments
| Amgen | Meals · 2021-10-19 | Repatha | $102 |
| Coloplast | Meals · 2021-09-21 | Restorelle | $62 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 96.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1154096196
- Licence
- CA 59728
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Physician assistant (363A00000X)
- Mailing address
- 6475 Camden Ave Ste 105, San Jose, CA, 95120
- NPI first listed
- 2021-08-11
- NPI last updated
- 2023-10-18
- NPI record certified
- 2023-10-18
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 575 Auto Center Dr, Watsonville, CA, 95076